AGENDA
The Agenda for the meeting is as follows:
Call to Order – John Musil, Pharm.D.,
Chairman
1 Roll Call of Task Force Members
2. Introduction of Members
(roundtable)
3. Review of items to be reviewed (charge of the task force)
Discussion and possible action regarding the Task Force’s review and recommendations for changes
and additions to the Pharmacy Compounding Rules and possible recommendation of new proposed
rules to the Board
A. Require PCAB accreditation? – Discussion/Action
B. Adopting USP <795> and <797> as the required standards – Discussion/Action
C. Rules for non-resident compounders – Discussion/Action
D. Patient specific compounding versus office supplies – Discussion/Action
E. Compounding during drug shortages – Discussion/Action
F. Separate (distinct) licensure as compounders? - Discussion/Action
G. Required competencies that must be demonstrated before initiating
compounding? - Discussion/Action
4. Call to the Public
The Task Force may make an open call to the public during the meeting, subject to
reasonable time, place, and manner restrictions, to allow individuals to address the Task
Force on any issue within its jurisdiction.
Pursuant to A.R.S. § 38-431.01 (G), members of the Task Force are not allowed to discuss
or take legal action on matters raised during an open call to the public unless the matters are
properly noticed for discussion and legal action. However, the Task Force may ask staff to
review a matter or may ask that a matter be placed on a future agenda.
5. Set next meeting date(s) – Discussion/Action
6. Adjournment
Source found here
No comments:
Post a Comment